ASBM Chairman Richard Dolinar, MD recently submitted another letter on naming to the World Health Organization Director-General, Dr. Margaret Chan, as well as the INN Expert Group, Department of Essential Medicines & Health Products, and the Health Systems & Innovation division at WHO.  The second letter is a result of ASBM’s keen interst in the 56th Consultaion on International Nonproprietary Names (INN) for Pharmaceutical Substances, which was held in May,  as well as the positive feedback ASBM received from Dr. Raffaella Balocco, INN Program Manager.

Read letter here.